Wright Medical Group Stock Forecast, Price & News

Wright Medical Group's stock was trading at $29.68 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, WMGI shares have increased by 1.0% and is now trading at $29.98.
View which stocks have been most impacted by COVID-19.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Wright Medical Group in the last year. There are currently 4 hold ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Wright Medical Group or view MarketBeat's top 5 stock picks.

Wall Street analysts have given Wright Medical Group a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Wright Medical Group wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Wright Medical Group is scheduled to release its next quarterly earnings announcement on Monday, February 22nd 2021.
View our earnings forecast for Wright Medical Group.

Wright Medical Group (NASDAQ:WMGI) posted its earnings results on Wednesday, August, 8th. The medical device company reported ($0.03) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.06) by $0.03. The medical device company had revenue of $205.40 million for the quarter, compared to analyst estimates of $197.20 million. Wright Medical Group had a negative return on equity of 3.86% and a negative net margin of 16.59%. The business's revenue was up 14.3% on a year-over-year basis. During the same period in the prior year, the firm posted ($0.07) earnings per share.
View Wright Medical Group's earnings history.

4 Wall Street analysts have issued 12-month target prices for Wright Medical Group's stock. Their forecasts range from $30.00 to $30.75. On average, they expect Wright Medical Group's share price to reach $30.38 in the next year. This suggests a possible upside of 1.3% from the stock's current price.
View analysts' price targets for Wright Medical Group.

Some companies that are related to Wright Medical Group include Abbott Laboratories (ABT), Medtronic (MDT), Stryker (SYK), Intuitive Surgical (ISRG), Becton, Dickinson and (BDX), Edwards Lifesciences (EW), Boston Scientific (BSX), IDEXX Laboratories (IDXX), Baxter International (BAX), DexCom (DXCM), ResMed (RMD), Hologic (HOLX), Teleflex (TFX), Insulet (PODD) and STERIS (STE).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Wright Medical Group investors own include Gilead Sciences (GILD), Exelixis (EXEL), Regeneron Pharmaceuticals (REGN), AbbVie (ABBV), Immunomedics (IMMU), Incyte (INCY), NVIDIA (NVDA), Pfizer (PFE), Sarepta Therapeutics (SRPT) and Agilent Technologies (A).

Wright Medical Group trades on the NASDAQ under the ticker symbol "WMGI."

Wright Medical Group's stock is owned by a number of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (7.60%), UBS Oconnor LLC (4.04%), P Schoenfeld Asset Management LP (3.48%), Carlson Capital L P (2.88%), Omni Partners LLP (2.74%) and PSquared Asset Management AG (2.71%). Company insiders that own Wright Medical Group stock include Andrew C Morton, Barry J Regan, David D Stevens, Elizabeth H Weatherman, James Lightman, Jennifer S Walker, John L Miclot, Jonathan Wesley Porter, Julie Andrews, Julie D Dewey, Kevin C Oboyle, Kevin D Cordell, Lance A Berry, Patrick Fisher, Richard F Wallman, Robert J Palmisano, Steven P Wallace and Tim Lanier.
View institutional ownership trends for Wright Medical Group.

WMGI stock was sold by a variety of institutional investors in the last quarter, including Zurcher Kantonalbank Zurich Cantonalbank, Carlson Capital L P, ARP Americas LP, BlackRock Inc., GW&K Investment Management LLC, DLD Asset Management LP, TIG Advisors LLC, and CNH Partners LLC. Company insiders that have sold Wright Medical Group company stock in the last year include Barry J Regan, James Lightman, Jennifer S Walker, John L Miclot, Julie Andrews, Kevin D Cordell, Steven P Wallace, and Tim Lanier.
View insider buying and selling activity for Wright Medical Group.

WMGI stock was bought by a variety of institutional investors in the last quarter, including UBS Oconnor LLC, Omni Partners LLP, PSquared Asset Management AG, Gardner Lewis Asset Management L P, Morgan Stanley, P Schoenfeld Asset Management LP, Anqa Management LLC, and Cowen AND Company LLC. Company insiders that have bought Wright Medical Group stock in the last two years include Barry J Regan, Elizabeth H Weatherman, Richard F Wallman, and Robert J Palmisano.
View insider buying and selling activity for Wright Medical Group.

Shares of WMGI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of WMGI stock can currently be purchased for approximately $29.98.

Wright Medical Group has a market capitalization of $3.90 billion and generates $920.90 million in revenue each year. The medical device company earns $-114,220,000.00 in net income (profit) each year or $0.06 on an earnings per share basis. Wright Medical Group employs 3,030 workers across the globe.

The official website for Wright Medical Group is www.wright.com.

Wright Medical Group's mailing address is PRINS BERNHARDPLEIN 200, AMSTERDAM P7, 38117. The medical device company can be reached via phone at 31-20-521-4777 or via email at [email protected]